Hr Positive Her2 Negative Advanced Breast Cancer Clinical Trials

ReadTheTrial indexes 1 studies for Hr Positive Her2 Negative Advanced Breast Cancer. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Hr Positive Her2 Negative Advanced Breast Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials for Hr Positive Her2 Negative Advanced Breast Cancer

A Open-label, Multicenter Phase II Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative Advanced Breast Cancer

NCT04796623 · COMPLETED · Phase 2

Frequently Asked Questions

What clinical trials are available for Hr Positive Her2 Negative Advanced Breast Cancer?

There are 1 clinical trials listed for Hr Positive Her2 Negative Advanced Breast Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Hr Positive Her2 Negative Advanced Breast Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Hr Positive Her2 Negative Advanced Breast Cancer trials in?

Current Hr Positive Her2 Negative Advanced Breast Cancer trials are distributed across: Phase 2 (1).

Find More Trials